2.19

0.92% 0.02

After Hours: 2.19

Cronos Group Inc (CRON)

Overview News Price History Option Chain Financials Discussions Forecast

Cronos Group Inc stock is traded at $2.19, with a volume of 995.94K. It is up +0.92% in the last 24 hours and down -3.10% over the past month. Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Previous Close:

$2.17

Open:

$2.14

24h Volume:

995.94K

Relative Volume:

1.03

Market Cap:

$829.55M

Revenue:

$87.89M

Net Income/Loss:

$-73.96M

P/E Ratio:

-5.7632

EPS:

-0.38

Net Cash Flow:

$-46.26M

1W Performance:

+1.86%

1M Performance:

-3.10%

6M Performance:

-16.09%

1Y Performance:

+9.50%

1-Day Range:

$2.14

$2.27

1-Week Range:

$2.07

$2.27

52-Week Range:

$1.70

$3.14

Cronos Group Inc Stock (CRON) Company Profile

Name

Cronos Group Inc

Sector

Healthcare (1190)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

(416) 504-0004

Address

4491 CONCESSION RD 12, STAYNER, ON

Employee

356

Twitter

@cronosgroup

Next Earnings Date

2024-08-08

Latest SEC Filings

CRON's Discussions on Twitter

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-02-22	Initiated	Bernstein	Mkt Perform
Jul-28-22	Upgrade	Canaccord Genuity	Hold → Buy
May-11-22	Upgrade	CIBC	Neutral → Sector Outperform
Mar-22-22	Upgrade	Barclays	Underweight → Equal Weight
Jan-27-22	Upgrade	Jefferies	Underperform → Hold
Nov-18-21	Resumed	BofA Securities	Underperform
Apr-28-21	Resumed	BofA Securities	Underperform
Feb-22-21	Downgrade	CIBC	Sector Outperform → Neutral
Jun-24-20	Upgrade	Raymond James	Mkt Perform → Outperform
Apr-27-20	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-14-20	Downgrade	Piper Sandler	Overweight → Neutral
Apr-02-20	Downgrade	BofA/Merrill	Buy → Neutral
Mar-31-20	Downgrade	Canaccord Genuity	Hold → Sell
Mar-04-20	Upgrade	MKM Partners	Neutral → Buy
Mar-03-20	Downgrade	Stifel	Buy → Hold
Oct-18-19	Upgrade	Stifel	Hold → Buy
Sep-20-19	Initiated	MKM Partners	Neutral
Sep-05-19	Upgrade	BMO Capital Markets	Underperform → Market Perform
Aug-13-19	Initiated	Piper Jaffray	Overweight
Aug-09-19	Upgrade	Canaccord Genuity	Sell → Hold
Jun-28-19	Initiated	Consumer Edge Research	Equal Weight
Jun-06-19	Initiated	Stifel	Hold
Jun-05-19	Upgrade	BofA/Merrill	Underperform → Buy
Apr-17-19	Initiated	BofA/Merrill	Underperform
Mar-27-19	Downgrade	Canaccord Genuity	Hold → Sell
Feb-25-19	Initiated	Jefferies	Underperform
Jan-18-19	Initiated	CIBC	Sector Outperform

View All

Cronos Group Inc Stock (CRON) Latest News

05:27 AM

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cronos Group (CRON) Investors with $250K+ Losses to Contact its Attorneys: May 11 Deadline Looming - AccessWire

Sep 22, 2024

Sep 20, 2024

Cronos Group (CRON) Stock Price, News & Analysis - MarketBeat

Sep 20, 2024

Sep 19, 2024

Cronos Group Inc. stock falls Thursday, underperforms market - MarketWatch

Sep 19, 2024

Sep 18, 2024

Cronos Group Inc. stock rises Wednesday, outperforms market - MarketWatch

Sep 18, 2024